Frontiers in Cellular and Infection Microbiology

Article	Citations
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development	528
Antibiotics as Major Disruptors of Gut Microbiota	350
ACE2, Much More Than Just a Receptor for SARS-COV-2	261
Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices	236
Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)	231
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields	208
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)	201
Role and Mechanism of Gut Microbiota in Human Disease	199
Antibiotic Resistance: One Health One World Outlook	191
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens	179
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China	174
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance	160
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species	143
SARS-COV-2 Variants: Differences and Potential of Immune Evasion	141
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey	135
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System	117
The Female Vaginal Microbiome in Health and Bacterial Vaginosis	114
The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders	111
Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential	110
Wuhan to World: The COVID-19 Pandemic	106
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression	106
Periodontal Disease: The Good, The Bad, and The Unknown	105
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria	104
Urinary Microbiome: Yin and Yang of the Urinary Tract	102
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine	102

Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan	98
Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders	97
The Gut Microbiota in Inflammatory Bowel Disease	97
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome	96
Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of CO	96
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics	96
Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs	95
Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives	91
Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities	90
Promising Therapeutic Strategies Against Microbial Biofilm Challenges	87
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro	87
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies	87
Chitosan-Based Nanoparticles Against Viral Infections	86
An Update on Molecular Diagnostics for COVID-19	85
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases	84
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease	82
Gut Microbiota Status in COVID-19: An Unrecognized Player?	81
Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis	80
A Novel Scoring System for Prediction of Disease Severity in COVID-19	80
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection	79
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review	78
Gut Microbiota and Diarrhea: An Updated Review	78
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection	78
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia	77
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy	76
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus	76
Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic	75
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium	74
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy	74
Proteus mirabilis Biofilm: Development and Therapeutic Strategies	74
An Overview of Anti-Eukaryotic T6SS Effectors	73
Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases	72
Gut Microbiome Reveals Specific Dysbiosis in Primary Osteoporosis	72
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy	71
Gardnerella vaginalis as a Cause of Bacterial Vaginosis: Appraisal of the Evidence From in vivo Models	71
Viral Infections, the Microbiome, and Probiotics	70
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples	69
Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility	68
A Human 2D Primary Organoid-Derived Epithelial Monolayer Model to Study Host-Pathogen Interaction in the Small Intestine	68
Bacterial Community Interactions During Chronic Respiratory Disease	67
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation	67
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance	67
Herpes Simplex Virus Cell Entry Mechanisms: An Update	66
How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches	65
Insights Into Mechanisms of Biofilm Formation in Acinetobacter baumannii and Implications for Uropathogenesis	65
Hypoxia Inducible Factor-1α: The Curator of Gut Homeostasis	65
The Microbiota of the Human Mammary Ecosystem	65
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome	65
Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection	64
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial	64

The Impact of Gut Microbiota on Radiation-Induced Enteritis	62
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota	62
C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens	61
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area	61
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants	60
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen	59
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions	59
RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact	59
Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities	59
Cutaneous Malassezia: Commensal, Pathogen, or Protector?	58
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis	58
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?	58
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review	58
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study	57
The Gut Microbiota of Critically Ill Patients With COVID-19	57
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection	57
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota	57
CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics	57
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing	57
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis	56
Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics	54
Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients	54
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease	54
Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli	53
The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People	53
Bacterial Vaginosis: What Do We Currently Know?	53
Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans	53
A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection	53
A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy	53
Bipolaris sorokiniana-Induced Black Point, Common Root Rot, and Spot Blotch Diseases of Wheat: A Review	53
Improving Pulmonary Infection Diagnosis with Metagenomic Next Generation Sequencing	52
Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases	52
Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer	51
The Anti-colitis Effect of Schisandra chinensis Polysaccharide Is Associated With the Regulation of the Composition and Metabolism of Gut Microbiota	51
Malassezia spp. Yeasts of Emerging Concern in Fungemia	51
Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future	51
Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection	50
Antimicrobial Activity of Lemongrass Essential Oil (Cymbopogon flexuosus) and Its Active Component Citral Against Dual-Species Biofilms of Staphylococcus aureus and Candida Species	50
Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation	50
Francisella tularensis, Tularemia and Serological Diagnosis	50
Influence of the Host and Parasite Strain on the Immune Response During Toxoplasma Infection	50
Antibiotic Resistance and Virulence Profiles of Klebsiella pneumoniae Strains Isolated From Different Clinical Sources	49
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19	49
Azole Use in Agriculture, Horticulture, and Wood Preservation – Is It Indispensable?	49
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar	49
Shining Light on Human Gut Bacteriophages	48
Oxidative Stress and Pathogenesis in Malaria	48
Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis	48
Fussing About Fission: Defining Variety Among Mainstream and Exotic Apicomplexan Cell Division Modes	48
Role of Cytokines in Experimental and Human Visceral Leishmaniasis	48
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation	47
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems	47
Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies	47
Determinants of Vaginal Microbiota Composition	47
Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study	47
Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?	47
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease	47
Pulsatilla chinensis Saponins Ameliorate Inflammation and DSS-Induced Ulcerative Colitis in Rats by Regulating the Composition and Diversity of Intestinal Flora	47
Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital	46
Amylases: Biofilm Inducer or Biofilm Inhibitor?	46
The Oral Microbiome in Periodontal Health	46
Alterations of the Gut Microbiome Composition and Lipid Metabolic Profile in Radiation Enteritis	46
Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections	46
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients	46
Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications	46
Regulations of Glycolytic Activities on Macrophages Functions in Tumor and Infectious Inflammation	45
Epidemiological Investigation and Antimicrobial Resistance Profiles of Salmonella Isolated From Breeder Chicken Hatcheries in Henan, China	45
Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach	45
Extracellular Vesicles in Trypanosomatids: Host Cell Communication	45
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway	45
Planctomycetes as Host-Associated Bacteria: A Perspective That Holds Promise for Their Future Isolations, by Mimicking Their Native Environmental Niches in Clinical Microbiology Laboratories	45
Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome	44
The Dynamic Roles of the Inner Membrane Complex in the Multiple Stages of the Malaria Parasite	43
The Diagnostic Value of Metagenomic Next–Generation Sequencing in Lower Respiratory Tract Infection	43
The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome	43
The Human Skin Microbiome in Selected Cutaneous Diseases	43
The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis	43
Block and Lock HIV Cure Strategies to Control the Latent Reservoir	43
Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract	43
Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages	43

Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach	43
Impact of Age and Sex on COVID-19 Severity Assessed From Radiologic and Clinical Findings	42
Association Between Oral Microbiota and Cigarette Smoking in the Chinese Population	42
Neuroinflammation, Sleep, and Circadian Rhythms	42
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic	42
The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections	41
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)	41
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota	41
Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections	41
Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Bl	41
Synergism of Streptococcus mutans and Candida albicans Reinforces Biofilm Maturation and Acidogenicity in Saliva: An In Vitro Study	41
Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis	41
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life	41
The Microbiome Composition of a Man's Penis Predicts Incident Bacterial Vaginosis in His Female Sex Partner With High Accuracy	40
Overview of the Potential Role of Malassezia in Gut Health and Disease	40
The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy	40
Antimicrobial Peptides Human Beta-Defensin-2 and -3 Protect the Gut During Candida albicans Infections Enhancing the Intestinal Barrier Integrity: In Vitro Study	40
Microbial Colonization From the Fetus to Early Childhood—A Comprehensive Review	40
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy	40
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis	39
Analytical and Clinical Evaluation of “AccuPower SARS-CoV-2 Multiplex RT-PCR kit (Bioneer, South Korea)” and “Allplex 2019-nCoV Assay (Seegene, South Korea)” for SARS-CoV-2 RT-PCR Diagnosis: Korean CD	39
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae	39
Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation	39
Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2	39
Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals	39
Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives	39
Vaginal Microbiome Composition in Early Pregnancy and Risk of Spontaneous Preterm and Early Term Birth Among African American Women	39
Role of Platelet Cytokines in Dengue Virus Infection	39
Mesoporous Hydroxyapatite/Chitosan Loaded With Recombinant-Human Amelogenin Could Enhance Antibacterial Effect and Promote Periodontal Regeneration	39
Virulence Regulation and Innate Host Response in the Pathogenicity of Vibrio cholerae	39
Altered Fecal Microbiota Composition in Older Adults With Frailty	39
TickSialoFam (TSFam): A Database That Helps to Classify Tick Salivary Proteins, a Review on Tick Salivary Protein Function and Evolution, With Considerations on the Tick Sialome Switching Phenomenon	39
Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography	38
Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors	38
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy	38
Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model	38
Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi	38
Gut Microbiota: Its Potential Roles in Pancreatic Cancer	38
Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions	38
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies	38
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells	38
Fecal and Serum Metabolomic Signatures and Microbial Community Profiling of Postmenopausal Osteoporosis Mice Model	38
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review	38
Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression	38
CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics	37
Analysis of Resistance to Florfenicol and the Related Mechanism of Dissemination in Different Animal-Derived Bacteria	37
Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects	37
Lactobacillus rhamnosus Strains Relieve Loperamide-Induced Constipation via Different Pathways Independent of Short-Chain Fatty Acids	37
Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury	37
Peptidylarginine Deiminase Inhibition Abolishes the Production of Large Extracellular Vesicles From Giardia intestinalis, Affecting Host-Pathogen Interactions by Hindering Adhesion to Host Cells	37
Tick Saliva and the Alpha-Gal Syndrome: Finding a Needle in a Haystack	37
Host Innate Immune Responses to Acinetobacter baumannii Infection	37
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets	37
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment	37
Factors Associated With MALDI-TOF Mass Spectral Quality of Species Identification in Clinical Routine Diagnostics	36
Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling	36
ACE2 Shedding and the Role in COVID-19	36
Poor Unstable Midgut Microbiome of Hard Ticks Contrasts With Abundant and Stable Monospecific Microbiome in Ovaries	36
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants	36
Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection	36
Host-Malaria Parasite Interactions and Impacts on Mutual Evolution	36
Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response	36
Recent Advances in Research on Antibacterial Metals and Alloys as Implant Materials	36
Revisiting Campylobacter jejuni Virulence and Fitness Factors: Role in Sensing, Adapting, and Competing	36
Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus	36
Drosophila as a Model Organism in Host–Pathogen Interaction Studies	35
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications	35
COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia	35
High-Fat Diet Induced Alteration of Mice Microbiota and the Functional Ability to Utilize Fructooligosaccharide for Ethanol Production	35
The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies	35
Diagnostic Methods, Clinical Guidelines, and Antibiotic Treatment for Group A Streptococcal Pharyngitis: A Narrative Review	35
Unraveling Pseudomonas aeruginosa and Candida albicans Communication in Coinfection Scenarios: Insights Through Network Analysis	35
Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study	35
Effects of Berberine on the Gastrointestinal Microbiota	34
Extracellular Histone H3 Induces Pyroptosis During Sepsis and May Act Through NOD2 and VSIG4/NLRP3 Pathways	34
A Study on the Prevalence and Subtype Diversity of the Intestinal Protist Blastocystis sp. in a Gut-Healthy Human Population in the Czech Republic	34
COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding	34
Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge	34
Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography	34
Interfering with Autophagy: The Opposing Strategies Deployed by Legionella pneumophila and Coxiella burnetii Effector Proteins	34
The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study	34
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension	34
Low-Abundant Microorganisms: The Human Microbiome’s Dark Matter, a Scoping Review	34
Forensic Analysis of Human Microbiome in Skin and Body Fluids Based on Geographic Location	33
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives	33
Phages in the Gut Ecosystem	33
The Fungal Microbiome and Asthma	33
Vaginal Microbiota and Cytokine Levels Predict Preterm Delivery in Asian Women	33
Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?	33
Impact of Coexistence Phenotype Between Staphylococcus aureus and Pseudomonas aeruginosa Isolates on Clinical Outcomes Among Cystic Fibrosis Patients	33
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection	33
Comprehensive Analysis of Non-coding RNA Profiles of Exosome-Like Vesicles From the Protoscoleces and Hydatid Cyst Fluid of Echinococcus granulosus	33
A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases	33
Measuring the Success of HIV-1 Cure Strategies	33
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease	33